American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$361M |
| 2 |
Gilead Sciences
GILD
|
+$216M |
| 3 |
Comerica
CMA
|
+$188M |
| 4 |
Zebra Technologies
ZBRA
|
+$155M |
| 5 |
Boston Scientific
BSX
|
+$151M |
Top Sells
| 1 |
Apple
AAPL
|
+$302M |
| 2 |
APC
Anadarko Petroleum
APC
|
+$284M |
| 3 |
Boeing
BA
|
+$271M |
| 4 |
Mondelez International
MDLZ
|
+$234M |
| 5 |
JPMorgan Chase
JPM
|
+$197M |
Sector Composition
| 1 | Financials | 16.82% |
| 2 | Healthcare | 15.61% |
| 3 | Technology | 15.09% |
| 4 | Consumer Discretionary | 11.61% |
| 5 | Industrials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
FibroGen
FGEN
$48.6M
| $3.67M | ﹤0.01% |
3,245
-8
| -0.2% | -$9.04K |
|
902
Palomar
PLMR
$3.13B
| $3.6M | ﹤0.01% |
+149,886
| New | +$3.6M |
|
903
Petrobras Class A
PBR.A
$75.2B
| $3.59M | ﹤0.01% |
252,861
-3,800
| -1% | -$54K |
|
904
Permian Resources
PR
$9.63B
| $3.58M | ﹤0.01% |
471,856
+157,850
| +50% | +$1.2M |
|
905
Voyager Therapeutics
VYGR
$232M
| $3.57M | ﹤0.01% |
131,131
-60,532
| -32% | -$1.65M |
|
906
TD Synnex
SNX
$12.5B
| $3.56M | ﹤0.01% |
+72,352
| New | +$3.56M |
|
907
Toronto Dominion Bank
TD
$131B
| $3.53M | ﹤0.01% |
60,460
+13,520
| +29% | +$790K |
|
|
PTLA
908
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $3.53M | ﹤0.01% |
129,976
+39,429
| +44% | +$1.07M |
|
909
Schwab International Small-Cap Equity ETF
SCHC
$4.9B
| $3.5M | ﹤0.01% |
+107,333
| New | +$3.5M |
|
910
Hawaiian Electric Industries
HE
$2.09B
| $3.45M | ﹤0.01% |
79,283
+67,658
| +582% | +$2.95M |
|
|
ONDK
911
DELISTED
On Deck Capital, Inc.
ONDK
| $3.45M | ﹤0.01% |
831,366
-138,330
| -14% | -$574K |
|
|
MDCO
912
DELISTED
Medicines Co
MDCO
| $3.45M | ﹤0.01% |
94,585
-275
| -0.3% | -$10K |
|
913
Graham Corp
GHM
$537M
| $3.44M | ﹤0.01% |
170,278
+92,135
| +118% | +$1.86M |
|
914
Snap
SNAP
$12.4B
| $3.39M | ﹤0.01% |
237,106
+201,479
| +566% | +$2.88M |
|
|
MEET
915
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $3.36M | ﹤0.01% |
964,699
+670,659
| +228% | +$2.33M |
|
916
Consolidated Edison
ED
$35.2B
| $3.35M | ﹤0.01% |
38,158
-1,064
| -3% | -$93.3K |
|
|
AIMT
917
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $3.34M | ﹤0.01% |
160,431
+26,201
| +20% | +$545K |
|
918
Spok Holdings
SPOK
$360M
| $3.31M | ﹤0.01% |
219,793
-56,886
| -21% | -$856K |
|
919
Great Lakes Dredge & Dock
GLDD
$821M
| $3.28M | ﹤0.01% |
297,038
+74,313
| +33% | +$820K |
|
920
MDU Resources
MDU
$3.32B
| $3.27M | ﹤0.01% |
333,656
+85,553
| +34% | +$839K |
|
921
HUB Group
HUBG
$2.2B
| $3.24M | ﹤0.01% |
154,502
+49,326
| +47% | +$1.04M |
|
|
GBT
922
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.23M | ﹤0.01% |
61,472
+14,293
| +30% | +$752K |
|
923
Insperity
NSP
$1.99B
| $3.23M | ﹤0.01% |
26,455
-4,354
| -14% | -$532K |
|
924
Best Buy
BBY
$15.9B
| $3.23M | ﹤0.01% |
46,255
+459
| +1% | +$32K |
|
|
AERI
925
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $3.21M | ﹤0.01% |
108,735
+24,720
| +29% | +$730K |
|